Invivoscribe

Invivoscribe is a global biotechnology company that develops and commercializes molecular diagnostic tests, including LeukoStrat CDx companion diagnostics and LeukoStrat/LymphoTrack/ClonoSEQ-type clonality and minimal residual disease assays for hematologic malignancies and immune disorders. It also provides clinical and pharma-services laboratories and standardized reagents for precision medicine. Its mission is to improve patient care by providing standardized diagnostic tools and services.